- Home
- ROIV vs BBDO Comparison
ROIV vs BBDO Comparison
Compare ROIV & BBDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | BBDO |
|---|---|---|
| Founded | 2014 | 1943 |
| Country | United Kingdom | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 33.6B |
| IPO Year | 2021 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ROIV | BBDO |
|---|---|---|
| Price | $35.43 | $3.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $48.08 | N/A |
| AVG Volume (30 Days) | ★ 6.0M | 77.2K |
| Earning Date | 11-09-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 4.84% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,260,000.00 | N/A |
| Revenue This Year | $530.75 | $9.69 |
| Revenue Next Year | $685.92 | $7.73 |
| P/E Ratio | ★ N/A | $9.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.99 | $2.66 |
| 52 Week High | $42.50 | $4.08 |
Technical Indicators
Market Signals| Indicator | ROIV | BBDO |
|---|---|---|
| Relative Strength Index (RSI) | 43.66 | 71.34 |
| Support Level | $33.15 | $2.96 |
| Resistance Level | $35.70 | N/A |
| Average True Range (ATR) | 1.14 | 0.15 |
| MACD | -0.34 | 0.09 |
| Stochastic Oscillator | 35.90 | 86.11 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BBDO Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation, a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.